Observational approach reveals dengue trends and thrombocytopenia in remote populations, suggesting vital intervention.
A BSTRACT Introduction: Dengue fever is a significant public health issue, affecting nearly 100 million people globally each year. Aim: This study investigates dengue infection trends, particularly focusing on thrombocytopenia and neurological symptoms in confirmed cases. Materials and Methods: A total of 1,558 blood samples were collected from probable dengue patients. Serological tests for NS1 antigen detection and IgM/IgG antibody titers were performed using enzyme-linked immunosorbent assay (ELISA). Results: In total, 166 samples (10.65%) out of 1,558 tested positive for dengue. IgM showed the highest positivity (40.47%), followed by NS1 antigen (37.5%). Males were more frequently affected than females, with a male-to-female ratio of 1.8:1. The age group of 21–30 years accounted for the largest number of cases (32.14%). Thrombocytopenia was observed in 88.09% of dengue-positive cases, with 26.19% having platelet counts below 50,000 cells/cumm. A few pediatric patients displayed severe neurological complications, including encephalitis, meningitis, and encephalopathy. Conclusion: This study highlights the importance of using IgG/IgM ratios to differentiate primary from secondary dengue infections; in addition, to control the severity of the disease, regular thrombocyte measurement is required and is highly recommended.
No takes yet. Share an insight, caveat, or question.
Soni et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: